New press release out today from the offices of Thought Leader Select:
July 7, 2010 (CHAPEL HILL, NC)—Thought Leader Select, a North Carolina company dedicated to delivering sophisticated key opinion leader research solutions to the biopharmaceutical industry, announces record year-over-year growth for the first six months of 2010.
In the first six months of the year, Thought Leader Select has eclipsed revenues for the first half of 2009 by 75 percent. In addition to the year-over-year growth comparison for the first half of each year, the company has also topped the annual mark it achieved for all of fiscal year 2009. Based on annualized revenue figures, the company has already grown by 35 percent through June 30, with anticipated business expected to double year-over-year revenues by the conclusion of 2010.
The company attributes its growth to several factors, including stellar work by its business development team, continued repeat business from key clients, significant investments in its web-based technology used for assembling medical expert teams for a variety of pre-launch activities for pharmaceutical clients, as well as the hiring of new research managers to increase its capacity to deliver timely assessments of key opinion leaders across multiple therapeutic areas and disease states.
“While many companies in our sector are struggling to remain competitive, we are thankful that our company has continued to develop its relationships with dozens of the world’s premier pharmaceutical companies,” stated Kristen Smithwick, vice president of sales, marketing, and strategic planning at Thought Leader Select. “Neil Mellor, who leads our business development team, along with Rhonda Napier and Lynda Scott, the newest additions to our research leadership team, have been instrumental in increasing our ability to identify new solutions for our clients and deliver them with precision and effectiveness. We still have several months to add on to what has already been a very bright year for us.”
“With growth comes responsibility, and we accept the challenge to be even more committed to helping our client companies optimize their relationships with medical experts to bring new medicines to the marketplace, “ stated Paul Meade, Thought Leader Select’s president and founder. “We are seizing this opportunity to make even more technology investments that will greatly benefit our clients, and we will continue to release cutting-edge products and services like our KOL Incubator and Professional Impact Network mapping solutions.”
About Thought Leader Select
Thought Leader Select is a specialty firm focused on providing solutions—research, technology tools and focused advice/consulting—for more effective KOL engagement and deployment in the healthcare industry. Thought Leader Select’s groundbreaking work bridges the areas of research, communications and technology. With more than 70 years of combined experience working in and with the pharmaceutical industry, Thought Leader Select is addressing needs for better engagement and more sophisticated deployment of KOLs during drug development and the life cycle of the brand.
Director of Global Marketing and Client Relations